MedTrace Logo

Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma

NCT02917473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2025-12-30

No results posted yet for this study

Summary

First-degree relatives of patients with melanoma have a greater risk of developing melanoma. Patients are advised orally to inform their first-degree relatives that they should protect their skin from UV radiation and ask for a skin examination from a general practitioner or dermatologist. The study will evaluate the effectiveness of a written sheet in addition to the usual oral counselling to increase acceptance of skin examination by the first-degree relatives. If effective, written counselling provided to the patient for relatives should be recommended and generalized.

Conditions

Interventions

BEHAVIORAL

In-person counseling

In-person counseling Sun protection

BEHAVIORAL

Written advice

Written advice

BEHAVIORAL

Medical skin screening

Medical skin screening

Sponsors & Collaborators

  • Institut national de la santé et de la recherche médicale, CIC 1415, TOURS

    collaborator UNKNOWN

  • Institut national de la santé et de la recherche médicale, U930,TOURS

    collaborator UNKNOWN

  • Institut d'Enseignement à Distance,University Paris - 8

    collaborator UNKNOWN

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Laurent MACHET, MD-PHD · University Hospital, Tours

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-13
Primary Completion
2019-04-26
Completion
2019-07-10

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917473 on ClinicalTrials.gov